We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ring-Shaped Device Reduces Pain of Drawing Blood

By HospiMedica International staff writers
Posted on 16 Dec 2010
A single use ring that fits around the middle finger allows quick and effective drawing of blood without need of a medical professional. More...


The Rapid Ring is an integrated device for sampling and testing blood from a human finger, comprised of a radially expandable, temporary clamp placed around the distal phalanx of the middle finger, a spring-loaded lancet for piercing the fingertip, and a testing platform for studying the blood sample directly after being drawn. The ring-type clamp applies pressure to the finger to create a region of increased blood volume and pressure, reducing the pain of the lancet. The close proximity of the device's components could also be an effective solution to the problem of drawing enough blood from the patient's finger.

The housing also contains a lateral opening for inserting the test strip, which has a small orifice on its surface to allow the lancet to pierce through it so that blood drawn automatically drips onto the strip. An optional capillary sponge can further facilitate the transfer of the sample to the test strip, which contains a predetermined amount of at least one reagent testing means. A blood volume window indicates when sufficient blood has been drawn for a particular test, and a second window indicates the test results.

The disposable device is intended for early detection of diseases and complications from AIDS; diagnosing health conditions such as elevated cholesterol; measuring glucose levels for monitoring diabetes; detecting the presence of illegal drugs and drugs of abuse; screening for pregnancy; measuring prothrombin time for monitoring blood thinning and clotting; detecting fecal occult blood to screen for colorectal cancer; and detecting luteinizing hormone to predict ovulation. The Rapid Ring is a product of RapidDX (Tel Aviv, Israel), a portfolio company of TechnoPlus Ventures (Tel Aviv, Israel), and has been approved by the US Food and Drug Administration (FDA).

Related Links:

TechnoPlus Ventures




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.